Acute pericarditis in a patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a case report and review of the literature on SARS-CoV-2 cardiological manifestations.

Coronavirus disease 2019 (COVID-19) cardiovascular manifestations case report pericarditis severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Journal

AME case reports
ISSN: 2523-1995
Titre abrégé: AME Case Rep
Pays: China
ID NLM: 101730832

Informations de publication

Date de publication:
2021
Historique:
received: 09 05 2020
accepted: 13 11 2020
entrez: 26 2 2021
pubmed: 27 2 2021
medline: 27 2 2021
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19) is known to cause a cluster of flu-like illnesses and pneumonia with evolving understanding of other systemic manifestations. Currently, the known cardiac manifestations of COVID-19 include myocardial injury, acute coronary syndrome, and arrhythmias. In this report, we describe a case of pericarditis-an unusual cardiac manifestation observed in a patient with COVID-19. A 63-year-old male presented with history of fever, cough and chest pain. Electrocardiogram (EKG) demonstrated diffuse ST-T wave changes on all the leads, with normal troponin-T levels. Echocardiograph showed mild pericardial effusion without any regional wall motion abnormality. Subsequent chest radiograph and coronary angiography were normal. In view of ongoing COVID-19 pandemic, nasopharyngeal swab was performed, which was positive. Detailed etiological workup for pericarditis, including infectious and inflammatory causes were unremarkable. Viral pericarditis (possibly caused by COVID-19) was diagnosis of exclusion and patient was treated with hydroxychloroquine 200 mg twice a day, colchicine 0.5 mg twice a day, and lopinavir/ritonavir 200 mg/50 mg tablet twice a day for 10 days during admission. He was discharged with hydroxychloroquine 200 mg twice daily and colchicine 0.5 mg once daily for 15 days. On subsequent follow-up clinic visit, he reported resolution of symptoms. The purpose of this report is to add a potential cardiovascular complication of COVID-19 to the literature. Awareness of this manifestation can lead to timely laboratory and imaging examinations with potential to provide correct treatment and good outcome.

Identifiants

pubmed: 33634246
doi: 10.21037/acr-20-90
pii: acr-05-20-90
pmc: PMC7882268
doi:

Types de publication

Case Reports

Langues

eng

Pagination

6

Informations de copyright

2021 AME Case Reports. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/acr-20-90). The authors have no conflicts of interest to declare.

Références

JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
J Clin Virol. 2020 Jun;127:104366
pubmed: 32302954
Circulation. 2020 Jun 9;141(23):1930-1936
pubmed: 32243205
Eur Heart J. 2020 Jun 7;41(22):2130
pubmed: 32227076
JACC Case Rep. 2020 Jul 15;2(9):1326-1330
pubmed: 32328588
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Eur Heart J. 2020 May 14;41(19):1861-1862
pubmed: 32267502
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
QJM. 2020 Jul 1;113(7):488-490
pubmed: 32311043
J Med Virol. 2020 Jul;92(7):819-823
pubmed: 32232979
Circ Res. 2016 Feb 5;118(3):496-514
pubmed: 26846643
JACC Heart Fail. 2020 Jun;8(6):515-517
pubmed: 32265149
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Eur Heart J. 2020 May 14;41(19):1859
pubmed: 32282027
Eur J Heart Fail. 2020 May;22(5):911-915
pubmed: 32275347
J Infect. 2020 Jun;80(6):639-645
pubmed: 32240670

Auteurs

Viral D Patel (VD)

Department of Internal Medicine, Sanjivani Hospital & Texas Heart Institute, Surat, Gujarat, India.

Khushbu H Patel (KH)

Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Dhairya A Lakhani (DA)

Department of Radiology, School of Medicine, West Virginia University, Morgantown, WV, USA.

Rupak Desai (R)

Division of Cardiology, Atlanta VA Medical Center, Decatur, GA, USA.

Deep Mehta (D)

Department of Clinical Research, Icahn school of Medicine at Mount Sinai, NY, USA.

Priyank Mody (P)

Department of Cardiology, Sanjivani Hospital & Texas Heart Institute, Surat, Gujarat, India.

Sumit Pruthi (S)

Department of Radiology, Vanderbilt University Medical Center, Nashville, TN, USA.

Classifications MeSH